Skip to content
Search

Latest Stories

Pharmacy bodies unite to enhance workforce wellbeing

Pharmacy bodies unite to enhance workforce wellbeing

The RPS/PS workforce wellbeing survey 2023revealed that most pharmacists continue to operate under challenging conditions, with elevated levels of burnout and stress 

The Royal Pharmaceutical Society’s (RPS) second roundtable on workforce wellbeing resulted in a series of collaborative actions to address pharmacy professionals' mental health and wellbeing challenges.


The roundtable brought together key stakeholders from the pharmacy sector, including organisations like the General Pharmaceutical Council (GPhC), Community Pharmacy England (CPE), the National Pharmacy Association (NPA), and the profession’s independent charity Pharmacist Support (PS).

A report detailing the outcomes of the meeting was published on Friday, highlighting the key areas of discussion and the agreed-upon actions by the participants.

During the roundtable, participants discussed the importance of understanding the workforce demographics, both nationally and locally, and using data to address wellbeing issues effectively.

They also emphasised the need for using supportive standards set by the General Pharmaceutical Council (GPhC) and the Care Quality Commission (CQC) quality statement to support and empower pharmacists’ wellbeing positively.

Furthermore, they called for increasing awareness of available support, embedding Protected learning time (PLT) in the workplace, and creating a supportive workplace culture conducive to wellbeing.

RPS and GPhC agreed to amplify the reach of the PS/RPS annual workforce wellbeing survey, while CPE and the NPA pledged to explore avenues for collaboration with Pharmacist Support to improve support for pharmacy managers.

Commitments were also made to review existing regulatory standards and promote those supportive of individual and team wellbeing.

“This second roundtable report underscores the importance of ongoing collaboration and proactive measures to create a healthier and more supportive work environment,” said RPS Director for England James Davies, who participated at the roundtable.

“There’s no quick fix or magic bullet to solve this complex issue, but ongoing focus by organisations working collaboratively together can definitely make a difference,” he added.

Highlighting the importance of creating positive workplace cultures to address workplace wellbeing issues, Danielle Hunt, CEO of Pharmacist Support, said: “It's essential that we create opportunities so that all voices can be heard and are valued, and that individuals feel empowered to raise concerns and seek support.”

“We believe by working together as a group we can create a profession where everyone feels valued and supported,” he added.

Actions agreed during the routable include:

  1. GPhC will collaborate with RPS and PS to support future workforce wellbeing surveys for all registrants, including pharmacy technicians.
  2. GPhC, RPS, and APTUK will work together to identify regulatory standards affecting WWB across the professions.
  3. CQC will identify and share quality standards related to workforce wellbeing with the group.
  4. All organisations will advocate for protected learning time and share successful implementation examples with RPS.
  5. Guild of Healthcare Pharmacists (GHP) and the Pharmacists' Defence Association (PDA) to use their position and legal rights to ensure adequate provision of learning time in the pharmacy workforce.
  6. Company Chemists’ Association (CCA) and NPA to explore opportunities with Pharmacist Support to promote PS Embracing a Wellbeing Culture Course to pharmacy managers and leaders.

Additionally, all organisations agreed to meet in six months to review progress and determine further actions.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less